A Mild Hyperthermia Hollow Carbon Nanozyme as Pyroptosis Inducer for Boosted Antitumor Immunity
- PMID: 37942890
- DOI: 10.1021/acsnano.3c07601
A Mild Hyperthermia Hollow Carbon Nanozyme as Pyroptosis Inducer for Boosted Antitumor Immunity
Abstract
The immune checkpoint blockade (ICB) antibody immunotherapy has demonstrated clinical benefits for multiple cancers. However, the efficacy of immunotherapy in tumors is suppressed by deficient tumor immunogenicity and immunosuppressive tumor microenvironments. Pyroptosis, a form of programmed cell death, can release tumor antigens, activate effective tumor immunogenicity, and improve the efficiency of ICB, but efficient pyroptosis for tumor treatment is currently limited. Herein, we show a mild hyperthermia-enhanced pyroptosis-mediated immunotherapy based on hollow carbon nanozyme, which can specifically amplify oxidative stress-triggered pyroptosis and synchronously magnify pyroptosis-mediated anticancer responses in the tumor microenvironment. The hollow carbon sphere modified with iron and copper atoms (HCS-FeCu) with multiple enzyme-mimicking activities has been engineered to induce cell pyroptosis via the radical oxygen species (ROS)-Tom20-Bax-Caspase 3-gasdermin E (GSDME) signaling pathway under light activation. Both in vitro and in vivo antineoplastic results confirm the superiority of HCS-FeCu nanozyme-induced pyroptosis. Moreover, the mild photothermal-activated pyroptosis combining anti-PD-1 can enhance antitumor immunotherapy. Theoretical calculations further indicate that the mild photothermal stimulation generates high-energy electrons and enhances the interaction between the HCS-FeCu surface and adsorbed oxygen, facilitating molecular oxygen activation, which improves the ROS production efficiency. This work presents an approach that effectively transforms immunologically "cold" tumors into "hot" ones, with significant implications for clinical immunotherapy.
Keywords: antitumor immunity; hollow structures; mild hyperthermia; nanozymes; pyroptosis.
Similar articles
-
Programmed Targeting Pyruvate Metabolism Therapy Amplified Single-Atom Nanozyme-Activated Pyroptosis for Immunotherapy.Adv Mater. 2024 Jun;36(24):e2312124. doi: 10.1002/adma.202312124. Epub 2024 Mar 14. Adv Mater. 2024. PMID: 38314930
-
Microenvironment-Responsive Prodrug-Induced Pyroptosis Boosts Cancer Immunotherapy.Adv Sci (Weinh). 2021 Dec;8(24):e2101840. doi: 10.1002/advs.202101840. Epub 2021 Oct 27. Adv Sci (Weinh). 2021. PMID: 34705343 Free PMC article.
-
Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis.Cell Res. 2018 Dec;28(12):1171-1185. doi: 10.1038/s41422-018-0090-y. Epub 2018 Oct 4. Cell Res. 2018. PMID: 30287942 Free PMC article.
-
Combination of Immunotherapy and Photo-pyroptosis as Novel Anticancer Strategy.Chembiochem. 2022 Aug 3;23(15):e202200201. doi: 10.1002/cbic.202200201. Epub 2022 May 6. Chembiochem. 2022. PMID: 35438233 Review.
-
Pyroptosis: A road to next-generation cancer immunotherapy.Semin Immunol. 2023 Jul;68:101782. doi: 10.1016/j.smim.2023.101782. Epub 2023 Jun 9. Semin Immunol. 2023. PMID: 37302166 Review.
Cited by
-
Towards precision medicine: design considerations for nanozymes in tumor treatment.J Transl Med. 2024 Nov 16;22(1):1033. doi: 10.1186/s12967-024-05845-w. J Transl Med. 2024. PMID: 39550581 Free PMC article. Review.
-
Water-filtered infrared A radiation hyperthermia combined with immunotherapy for advanced gastrointestinal tumours.Cancer Med. 2024 Jul;13(14):e70024. doi: 10.1002/cam4.70024. Cancer Med. 2024. PMID: 39049187 Free PMC article.
-
A thermoresponsive nanocomposite integrates NIR-II-absorbing small molecule with lonidamine for pyroptosis-promoted synergistic immunotherapy.J Nanobiotechnology. 2024 Apr 10;22(1):163. doi: 10.1186/s12951-024-02424-5. J Nanobiotechnology. 2024. PMID: 38600506 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials